Effect of adenosine A2 receptor stimulation on platelet activation–aggregation: Differences between canine and human models
- 1 January 2008
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 121 (5) , 689-698
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Preclinical Evaluation of S18886 in an Experimental Model of Coronary Arterial ThrombosisJournal of Cardiovascular Pharmacology, 2006
- Preconditioning ischemia attenuates molecular indices of platelet activation‐aggregationJournal of Thrombosis and Haemostasis, 2006
- The Preparation and Characterization of Novel Peptide Antagonists to Thrombin and Factor VIIa and Activation of Protease-Activated Receptor 1The Journal of Pharmacology and Experimental Therapeutics, 2004
- Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs.Journal of Clinical Investigation, 1998
- Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics?Pathophysiology of Haemostasis and Thrombosis, 1996
- Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.Journal of Clinical Investigation, 1994
- In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbitEuropean Journal of Pharmacology, 1994
- Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.Journal of Clinical Investigation, 1993
- Measuring platelet and leucocyte aggregation/adhesion responses in very small volumes of whole bloodJournal of Pharmacological Methods, 1981
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976